The Effect of Oxygen Exposure During Newborn Resuscitation on Lung Injury
Oxygen Exposure During Newborn Resuscitation and Pulmonary Oxidative Stress
1 other identifier
interventional
30
1 country
1
Brief Summary
Hypothesis: In this feasibility study, hyperoxemia, as approximated by transcutaneous hemoglobin saturation with oxygen (Sp02), at the time of birth will cause sustained pulmonary oxidative stress as demonstrated by elevation of pulmonary protein carbonyl. Furthermore, this oxidative stress will be directly proportional to the imposed oxygen-burden during resuscitation at the time of birth. This study will give us information regarding the magnitude of protein carbonyl elevation in the preterm infant. With these results we will be able to 1. establish the technique for the running or protein carbonyl assays and 2. calculate an appropriate sample size for a future randomized control trial.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2005
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2005
CompletedFirst Submitted
Initial submission to the registry
July 22, 2006
CompletedFirst Posted
Study publicly available on registry
July 25, 2006
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2006
CompletedNovember 7, 2006
November 1, 2006
July 22, 2006
November 6, 2006
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
protein carbonyl concentration in the tracheal aspirate on day 1
Secondary Outcomes (5)
protein carbonyl concentration in the tracheal aspirate on day 3
protein carbonyl concentration in the tracheal aspirate on day 7
protein carbonyl concentration in the tracheal aspirate on day 14
protein carbonyl concentration in the tracheal aspirate on day 21
protein carbonyl concentration in the tracheal aspirate on day 28
Interventions
Eligibility Criteria
You may qualify if:
- \<=32 weeks gestation
- inborn
- require intubation
You may not qualify if:
- lethal anomalies
- cyanotic congenital heart disease
- known hemoglobinopathy
- risk factors for persistent pulmonary hypertension
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Calgarylead
- Equipment loan from Masimo Corp.collaborator
Study Sites (1)
Canada
Calgary, Alberta, T2N 2T9, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yacov Rabi, MD, FRCPC
University of Calgary
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
July 22, 2006
First Posted
July 25, 2006
Study Start
July 1, 2005
Study Completion
October 1, 2006
Last Updated
November 7, 2006
Record last verified: 2006-11